Recovery of human immunodeficiency virus type 1 from semen: minimal impact of stage of infection and current antiviral chemotherapy.
about
Pathogenesis of human immunodeficiency virus infectionTargeting Trojan Horse leukocytes for HIV prevention.HIV infection of the male genital tract--consequences for sexual transmission and reproduction.Antiretroviral-drug concentrations in semen: implications for sexual transmission of human immunodeficiency virus type 1Acute mucosal pathogenesis of feline immunodeficiency virus is independent of viral dose in vaginally infected cats.Multicenter evaluation of methods to quantitate human immunodeficiency virus type 1 RNA in seminal plasmaPrior mucosal exposure to heterologous cells alters the pathogenesis of cell-associated mucosal feline immunodeficiency virus challenge.Antiretroviral drug concentrations in semen of HIV-1 infected menBinding of LFA-1 (CD11a) to intercellular adhesion molecule 3 (ICAM-3; CD50) and ICAM-2 (CD102) triggers transmigration of human immunodeficiency virus type 1-infected monocytes through mucosal epithelial cells.Hydrogels containing monocaprin have potent microbicidal activities against sexually transmitted viruses and bacteria in vitroConsiderations and development of topical microbicides to inhibit the sexual transmission of HIV.Assisted reproduction in HIV and HCV infected men of serodiscordant couples.Presence of human immunodeficiency virus nucleic acids in wastewater and their detection by polymerase chain reactionHIV-1 nucleic acids localize to the spermatogonia and their progeny. A study by polymerase chain reaction in situ hybridization.Detection of feline immunodeficiency virus in semen from seropositive domestic cats (Felis catus)High viral load in semen of human immunodeficiency virus type 1-infected men at all stages of disease and its reduction by therapy with protease and nonnucleoside reverse transcriptase inhibitors.Antiviral therapy: current concepts and practicesEnhanced immunity to human immunodeficiency virus (HIV) envelope elicited by a combined vaccine regimen consisting of priming with a vaccinia recombinant expressing HIV envelope and boosting with gp160 proteinHIV treatment as prevention and HPTN 052.Neutrophils from human immunodeficiency virus (HIV)-seronegative donors induce HIV replication from HIV-infected patients' mononuclear cells and cell lines: an in vitro model of HIV transmission facilitated by Chlamydia trachomatis.Efficient production of human immunodeficiency virus proteins in transgenic mice.Paternal HIV infection and transfer of HIV from mother to fetus.Lower levels of HIV RNA in semen in HIV-2 compared with HIV-1 infection: implications for differences in transmission.Detection of classical swine fever virus in boar semen by reverse transcription-polymerase chain reaction.Is an AIDS vaccine possible?Mucosal challenge with cell-associated or cell-free feline immunodeficiency virus induces rapid and distinctly different patterns of phenotypic change in the mucosal and systemic immune systems.HIV and sexually transmitted diseases.
P2860
Q24634681-375894DA-95E6-44FC-921D-7139FA43D9FCQ33518390-31DA68F7-BCBE-4109-9D59-564300825FA8Q33629797-78310F7C-398F-4A18-A67F-DDE2F31E039DQ33700962-8DBA3E1F-107C-4467-BDDE-160644417057Q33715758-27FD8749-90A7-4ED7-AE9E-50540816192EQ33967524-16A8DEFB-769D-401D-BE78-AEAD78C0D73FQ33968779-2A6DCBC5-3EA8-43A5-AD40-235970E6E9FFQ34131446-A5DB925F-DAA6-4C30-BF2C-9A3BD71B931AQ34326489-9CBA515B-89CA-4F5F-A3F1-CC1A23DCA27CQ34504599-E64D55D6-719D-4144-B7A5-6EE81F92A48DQ34768558-C304C5FC-814F-43C1-A09C-5A63CB8F21D9Q35648406-8206B266-7AF3-4FCD-A11F-70FA31AD1A96Q35699303-B14685E3-5541-44CE-B70E-156525C460D0Q35834129-AE623440-D9A7-4652-82DE-6D9AE0C243B9Q35851492-A6607FBC-DC01-4447-937D-9A12E88B9CDFQ35890788-5AC57C97-2EEF-4756-A0A4-92B0FE8E0022Q36070394-1130370E-E8E3-4753-9E35-4F1ABC817446Q36137980-48E1B2FC-094E-4EF0-8B9D-B5C5FE5E5843Q36364604-11CA6BF9-2E6B-417D-8629-97EC4E11837EQ36364732-8FA639FE-E903-40AD-B4B0-C6E00F72953AQ36698495-86C450CC-F669-4B9E-AF28-B6869E0E5CE1Q36884370-C4008C3C-9DF2-4E74-8630-EBB355C0A70AQ37052996-EF168556-5ABC-442A-B1D9-FE69F3828FE0Q40565629-766715F6-7228-4220-81A2-ED41C3177F8DQ43881637-136E5DA2-16C8-4ACF-AB6C-1418DF1592B9Q44870958-AB21F68D-0C1A-4774-B7C9-9176D52048A9Q49908758-79CA0139-F47A-4F2A-A686-21D649E82515
P2860
Recovery of human immunodeficiency virus type 1 from semen: minimal impact of stage of infection and current antiviral chemotherapy.
description
1991 nî lūn-bûn
@nan
1991年の論文
@ja
1991年学术文章
@wuu
1991年学术文章
@zh
1991年学术文章
@zh-cn
1991年学术文章
@zh-hans
1991年学术文章
@zh-my
1991年学术文章
@zh-sg
1991年學術文章
@yue
1991年學術文章
@zh-hant
name
Recovery of human immunodefici ...... urrent antiviral chemotherapy.
@en
Recovery of human immunodefici ...... urrent antiviral chemotherapy.
@nl
type
label
Recovery of human immunodefici ...... urrent antiviral chemotherapy.
@en
Recovery of human immunodefici ...... urrent antiviral chemotherapy.
@nl
prefLabel
Recovery of human immunodefici ...... urrent antiviral chemotherapy.
@en
Recovery of human immunodefici ...... urrent antiviral chemotherapy.
@nl
P2093
P356
P1476
Recovery of human immunodefici ...... urrent antiviral chemotherapy.
@en
P2093
Chaloupka K
Collier AC
Cummings DK
Krieger JN
P304
P356
10.1093/INFDIS/163.2.386
P407
P577
1991-02-01T00:00:00Z